HeartSciences Q1 FY2027: Cash Drops to $30K, Equity Turns Negative, Nasdaq Delisting Notice
HSCS has more than doubled off its 52-week low of $1.63.
Summary
HeartSciences' Q1 FY2027 shows cash nearly depleted at $29,906, negative stockholders' equity of $2.03 million, and a Nasdaq delisting notice. The company is relying on the pending Fortitude merger to survive.
Key Events · Earnings and Guidance · HSCS
-
Cash Nearly Depleted
Cash and cash equivalents fell to $29,906 as of July 31, 2026, from $1,656,814 at April 30, 2026 — a 98% decline in one quarter.
-
Stockholders' Equity Turns Negative
Total stockholders' equity swung to a deficit of $2,033,145 from positive $226,060, driven by a $3.17 million net loss and $738,889 in stock-based compensation.
-
Nasdaq Delisting Notice
Received August 4, 2026 for failing the $2.5 million minimum stockholders' equity requirement. Compliance plan due September 18, 2026; extension possible to January 31, 2027.
-
Going Concern Reaffirmed
Management states existing cash is insufficient to fund operations for the next twelve months, raising substantial doubt about the company's ability to continue as a going concern.
Analysis · HSCS · Crypto Assets
The first-quarter report reveals a company running out of cash. Cash fell from $1.66 million to just $29,906 in three months, and stockholders' equity swung from positive $226,060 to a deficit of $2.03 million. Nasdaq has already sent a delisting notice for failing the $2.5 million minimum equity requirement, with a compliance plan due September 18, 2026. Survival now hinges entirely on closing the Fortitude Mining merger, which remains subject to shareholder approval. The $1.0 million private placement from Fortitude and $1.2 million in ATM sales after quarter-end provide only a short runway. This is a critical liquidity event for a company already under a going-concern warning.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 40.7% of the 383 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSCS was trading at $3.54 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $13.8M. The 52-week trading range was $1.63 to $4.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.